List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 489 studies with search of: "Schering-Plough" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)
Condition: Hepatitis C, Chronic
Intervention: Drug: Combination of pegylated interferon alfa-2b and ribavirin
2 Completed A Patient Handling Study of MF/F MDI With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703)(COMPLETED)
Conditions: Asthma;   COPD
Intervention: Drug: SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
3 Active, not recruiting Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM1)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (SCH 503034);   Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908);   Drug: Boceprevir placebo
4 Not yet recruiting Acute Effects of SCH 420814 on Dyskinesia and Parkinsonism in Levodopa Treated Patients (Study P05550AM1)
Conditions: Movement Disorders;   Dyskinesias;   Neurodegenerative Diseases;   Central Nervous System Diseases;   Brain Diseases
Interventions: Drug: Preladenant;   Drug: Preladenant;   Drug: Levodopa infusion (IV);   Drug: Carbidopa;   Drug: Placebo matched to preladenant;   Drug: Placebo matched to Levodopa infusion (IV);   Drug: Placebo matched to Carbidopa 25-mg
5 Completed Study to Evaluate the Safety and Dose-Range of SCH 527123 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (Study P04592AM4)(COMPLETED)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Drug 1: SCH 527123;   Drug: Drug 2: Placebo to match SCH 527123;   Drug: Drug 3: SCH 527123;   Drug: Drug 4: Placebo to match SCH 527123;   Drug: Drug 5: SCH 527123;   Drug: Drug 6: Placebo to match SCH 527123;   Drug: Drug 7: SCH 527123;   Drug: Drug 8: SCH 527123;   Drug: Drug 9: SCH 527123;   Drug: Drug 10: Placebo to match SCH 527123
6 Active, not recruiting A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612AM2)
Condition: Psoriasis
Intervention: Biological: Infliximab
7 Not yet recruiting The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633)
Conditions: Coronary Artery Bypass;   Myocardial Infarction;   Ventricular Dysfunction, Left;   Stroke;   Cardiopulmonary Bypass
Interventions: Drug: Acadesine;   Drug: Normal Saline
8 Completed Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia (Study P02579AM)(COMPLETED)
Condition: Hypercholesterolemia
Intervention: Drug: ezetimibe
9 Completed Neutrophilic Asthma Study With SCH 527123 (Study P05365AM2)(COMPLETED)
Condition: Neutrophilic Asthma
Interventions: Drug: SCH 527123;   Drug: Placebo
10 Recruiting Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage IIIB/IV Non-Small Cell Lung Cancer Patients (Study P05146AM3)
Conditions: Carcinoma, Non-Small-Cell Lung;   Adenocarcinoma;   Carcinoma, Large Cell;   Carcinoma, Squamous Cell
Intervention: Drug: Temozolomide
11 Completed Trial to Assess the Safety and Effects of SCH 530348 in Japanese Subjects With Acute Coronary Syndrome (P04772)(COMPLETED)
Conditions: Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction
Interventions: Drug: SCH 530348;   Drug: Placebo;   Drug: Aspirin;   Drug: Ticlopidine hydrochloride
12 Completed Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Condition: Allergies
Interventions: Drug: Desloratadine;   Drug: Zyrtec® (cetirizine)
13 Completed Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)(COMPLETED)
Conditions: Hypercholesterolemia;   Coronary Heart Disease
Interventions: Drug: ezetimibe;   Drug: placebo
14 Completed This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)
Condition: Seasonal Allergic Rhinitis
Intervention: Drug: mometasone furoate
15 Completed Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)(COMPLETED)
Conditions: Hypercholesterolemia;   Atherosclerosis
Interventions: Drug: Ezetimibe;   Drug: Placebo
16 Completed A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)(COMPLETED)
Condition: Rheumatoid Arthritis
Intervention: Drug: Infliximab
17 Recruiting Study of Response in CHC Patients Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (Study P04823AM2)
Conditions: Hepatitis C, Chronic;   Insulin Resistance
Intervention: Drug: Combination of pegylated interferon alfa-2b and ribavirin
18 Recruiting Remicade Infusion Management Program (Study P04466)
Conditions: Crohn Disease;   Rheumatoid Arthritis
Intervention: Biological: Infliximab
19 Recruiting Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)
Conditions: Hepatitis C, Chronic;   Hepacivirus
Interventions: Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908)
20 Completed Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)
Condition: Allergic Rhinitis
Interventions: Drug: Mometasone furoate nasal spray (MFNS);   Drug: Matching placebo nasal spray

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options